Medindia

X

Carna Biosciences Signs Distribution Agreement with Shanghai Universal Biotech Company

Tuesday, October 28, 2008 General News J E 4
Advertisement
KOBE, Japan, Oct. 27 Carna Biosciences, Inc. ("Carna") announced on October 27, 2008, the signing of a Distribution Agreement with Shanghai Universal Biotech Company ("SUBC"). Under the terms of this Agreement, SUBC will become the exclusive distributor of Carna's Protein Kinases within China.



With China's emergence as a strong market opportunity, particularly in the life sciences, major biopharmaceutical companies have now established research and production facilities in Shanghai and other regions of China. These facilities seek and require goods to support their internal drug discovery programs. Carna is an established global provider of protein kinases used in the discovery and development of the important class of drugs known as kinase inhibitors. The Agreement with SUBC makes these products readily available to Chinese researchers via SUBC's strong distribution channels.



In addition to major biopharmaceutical presence, tax incentives provided by the Chinese government have provided a fertile environment for the establishment of bio-venture companies and CRO. The Agreement between Carna and SUBC, with its offices in the major cities of Shanghai and Beijing, is anticipated to lead to significantly increased sales opportunities for Carna and further establish its reputation as a global provider of protein kinases.



About Carna

Carna Biosciences, Inc. (http://www.carnabio.com/english/), founded in April 2003, is a Japanese biotechnology company conducting intercellular signaling-based drug discovery programs, and providing drug discovery services to pharmaceutical companies using proprietary technologies in gene cloning, active kinase protein expression, protein purification and homogeneous assay development. The products and services provided by Carna include kinase proteins, assay development services, kinase profiling and screening services, and crystallography products and services.



About SUBC

Shanghai Universal Biotech Company(www.univ-bio.com), founded in December 2004, is a Chinese distributor of biological reagents and experimental installations. The company provides antibody and reagent products as an agent of biological companies at home and abroad.



Contact: Tomohisa Yamazaki, Manager Corporate Planning Carna Biosciences, Inc. Phone: +81-78-302-7039 Fax: +81-78-302-6665 E-mail: ir-team@carnabio.com URL: http://www.carnabio.com/english/

SOURCE Carna Biosciences, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Maclaren Appoints New President and New Chief Oper...
S
Relations PR & Marketing Named Agency of Record fo...